Angiotensin II therapy in refractory septic shock: which patient can benefit most? A narrative review
Abstract Patients with septic shock who experience refractory hypotension despite adequate fluid resuscitation and high-dose noradrenaline have high mortality rates. To improve outcomes, evidence-based guidelines recommend starting a second vasopressor, such as vasopressin, if noradrenaline doses ex...
| প্রধান লেখক: | , , , , , , , , |
|---|---|
| বিন্যাস: | প্রবন্ধ |
| ভাষা: | English |
| প্রকাশিত: |
BMC
2024-02-01
|
| মালা: | Journal of Anesthesia, Analgesia and Critical Care |
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://doi.org/10.1186/s44158-024-00150-w |